Pharmaceutical Executive February 5, 2025
Hiroyuki Okuzawa will step into the role starting in April.
Daiichi Sankyo announced that Hiroyuki Okuzawa will serve as its new CEO starting on April 1, 2025.1 The previous CEO, Sumao Manabe, DVM, PhD, will continue to serve as representative director and executive chairperson.
Okuzawa will also serve as representative director and president. Prior to this, he served as chief operating officer of the company.
In a press release, Okuzawa said, “I am deeply honored to be the next CEO of Daiichi Sankyo and will follow Sunao Manabe’s exceptional leadership and unwavering commitment to patients and their families. Building on this foundation, I will continue to leverage Daiichi Sankyo’s strengths in science and technology, and will continuously develop our talent...
Today's Sponsors
Today's Sponsor